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Abstract—We recently found that endogenous (free fatty acids) and pharmacological (thiazolidinediones) agonists of
nuclear receptor Peroxisome proliferator-activated receptor (PPAR) stimulate renin transcription. In addition, the renin
gene was identified as a direct target of PPAR. The mouse renin gene is regulated by PPAR through a distal enhancer
direct repeat closely related to consensus PPAR response element (PPRE). In vitro studies demonstrated that PPAR
knockdown stimulated PPRE-driven transcription. These data predicted that deficiency of PPAR would upregulate
mouse renin expression. Consistent with these observations knockdown of PPAR increased the transcription of a
reporter gene driven by the mouse renin PPRE-like motif in vitro. To study the impact of PPAR on renin production
in vivo, we used a cre/lox system to generate double-transgenic mice with disrupted PPAR locus in renin-producing
juxtaglomerular (JG) cells of the kidney (RC-PPARfl/fl mice). We provide evidence that PPAR expression was
effectively reduced in JG cells of RC-PPARfl/fl mice. Fluorescent immunohistochemistry showed stronger renin signal
in RC-PPARfl/fl than in littermate control RC-PPARwt/wt mice. Renin mRNA levels and plasma renin concentration
in RC-PPARfl/fl mice were almost 2-fold higher than in littermate controls. Arterial blood pressure and pressure control
of renal vascular resistance, which play decisive roles in the regulation of renin production were indistinguishable
between RC-PPARwt/wt and RC-PPARfl/fl mice. These data demonstrate that the JG-specific PPAR deficiency
results in increased mouse renin expression in vivo thus corroborating earlier in vitro results. PPAR appears to be a
relevant transcription factor for the control of renin gene in JG cells. (Hypertension. 2010;55:660-666.)
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The nuclear receptor peroxisome proliferator-activatedreceptor (PPAR) is the molecular master switch of
adipocyte growth and differentiation,1 but an important role
of PPAR in the cardiovascular system is gaining recogni-
tion.2,3 A series of compelling studies has demonstrated that
PPAR is involved in the regulation of vascular tone and in
the pathogenesis of vascular diseases such as arterial hyper-
tension or atherosclerosis.2–6 Thiazolidinediones, which are
pharmacological PPAR agonists, have various and to some
extent opposing effects on blood pressure, vascular perme-
ability and cardiac function.2,3,6–10
Renin is a key factor in the regulation of blood pressure and
fluid/electrolyte homeostasis.11 Renin is produced mainly in
the kidney cortex by a small population of epithelial-like cells
called “juxtaglomerular” (JG) located in the glomerular end
of the afferent arteriole. The transcription of the renin gene is
one of the regulated checkpoints in the overall renin synthe-
sis.12 We recently identified PPAR as a transcription factor
that controls renin expression in renin-producing cells.13,14
We hypothesize that the effect of PPAR on renin gene
transcription is an additional molecular mechanism whereby
PPAR influences the function of the cardiovascular system.
PPAR targets two functionally different cis-acting ele-
ments in the 5-flanking region of the renin promoter. First, a
direct repeat motif highly similar to canonical PPAR response
element (PPRE) is located in a distal regulatory region known
as the renal renin enhancer.13,15 We identified a second,
atypical PPAR-binding site termed Pal3 in the proximal
renin promoter.13 Thus, the renin gene contains two diverse
and widely separated PPAR-binding sequences. The renin
Pal3 and PPRE motifs have different protein-binding and
functional properties.14 The proximal promoter Pal3 site is
decisive for the regulation of human renin transcription. On
the contrary, the mouse renin gene was targeted by PPAR
through the enhancer PPRE-like sequence because the mouse
Pal3 element was transcriptionally silent in response to PPAR
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activation. PPAR knockdown decreased Pal3-driven transcrip-
tion but unexpectedly increased PPRE-driven transcription in
renin-producing cells.14 The increase of PPRE-driven transcrip-
tion on PPAR deficiency correlated with increased protein
binding to PPRE (presumably of other nuclear receptors), a
phenomenon that was not observed with Pal3.14
Altogether our findings suggested that PPAR influences
renin transcription in a species-dependent manner.14 Because
the information regarding PPAR was obtained using in vitro
systems, it is necessary to determine whether PPAR regu-
lates renin expression in vivo. To study the in vivo relevance
of PPAR in the cellular control of renin gene expression we
used a conditional deletion. This approach provides an
opportunity to discriminate the role of PPAR in the cellular
control of renin transcription from PPAR-dependent influ-
ence on systemic signals known to regulate renin production.
We generated double-transgenic mice with a selective
PPAR knockout in the renin-producing cells.
Methods
Cell Culture
Human renin-producing Calu-6 cells (ATCC no. HTB-56) were
cultured in Eagle’s minimal essential medium supplemented with
10% FBS, sodium pyruvate, 100 U/mL penicillin, 100 g/mL
streptomycin, and 1% nonessential amino acids at 37°C in a
humidified atmosphere containing 5% CO2.
Plasmid
The construct mPPREmPal3 represents a firefly luciferase reporter
gene driven by a 46-bp-long mouse renin enhancer fragment con-
taining a cAMP response element and the PPRE-like element
(originally described as Ec/Eb and also termed hormone response
element [HRE])13,14 cloned into the 5 end of the minimal human
renin promoter hRenMin in which Pal3 is replaced by mouse Pal3.
Animals
The mice expressing cre recombinase under the control of endoge-
nous renin promoter (Ren-cre) or PPAR-floxed allele (obtained
through The Jackson Laboratory) were described previously.16,17 All
animal experiments were performed according to the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals and were approved by the local ethics committee. Two- to
4-month-old F3 to F7 male mice were used for the experiments.
Blood Pressure Measurements
Systolic blood pressure was measured by the tail-cuff method. Mice
were put in a steel cover on a 30°C prewarmed platform and trained
for 7 days between 9:00 AM and 12:00 AM before the measurement.
Data from 5 to 8 measurements per animal were averaged for a single
value.
Statistics
All data are presented as meansSEM. Differences were analyzed
by ANOVA and the Student’s unpaired t test. P0.05 was
considered significant.
Results
Knockdown of PPAR Upregulates the Basal
Activity of a Reporter Gene Driven by the Mouse
Renin PPRE-Like Sequence In Vitro
We found previously that PPAR deficiency increases PPRE-
driven transcription and that mouse renin gene is targeted by
PPAR at the enhancer PPRE-like sequence.13,14 To provide
further evidence that the mouse renin gene is upregulated by
PPAR deficiency in renin-producing cells, we used a re-
porter driven by a human renin promoter construct containing
the mouse renin enhancer PPRE-like site (mPPREmPal3).
Knockdown of PPAR by sequence-specific small interfering
(si)RNA in the renin-producing Calu-6 cells led to an almost
2-fold increase in the transcription of mPPREmPal3 construct
(Figure 1A and 1B). These data demonstrated that the
transcription of mouse renin PPRE-like–driven reporter is
upregulated by PPAR deficiency in vitro.
Generation of JG-Specific PPAR Knockout Mice
To study the role of PPAR deficiency in the cell-specific
control of the renin gene in vivo, we used the cre/lox
recombination system to generate mice with deletion of
PPAR in JG cells. Mice expressing cre recombinase under
the control of the renin locus were crossed to a second
transgenic strain in which PPAR exons 1 and 2 were flanked
by loxP sites.16,17 The floxed PPAR allele is deleted upon
expression of cre recombinase. It has been previously shown
that expression of cre recombinase from the endogenous
renin locus targets recombination to the renin-producing
cells.17 Nine genotypes were obtained from crossing of
double-heterozygous mice (see Figure S1A in the online Data
Supplement, available at http://hyper.ahajournals.org). Be-
cause we needed endogenous renin as a readout, animals with
only 2 of the 9 possible genotypes in the offspring were used:
as littermate control, mice with heterozygous renin/cre alleles
and wild-type homozygous PPAR alleles (RC-PPARwt/wt);
and as JG-specific PPAR knockout, mice with heterozygous
renin/cre alleles and floxed homozygous PPAR alleles
(RC-PPARfl/fl). Cre-positive mice were used in all of the
studies to ensure that the littermate control and the PPAR-
deficient mice contained one allele of Ren1 and one allele of
Ren2 (see online Figure S1A). As expected, recombined
PPAR transcript was reproducibly detected only in kidneys
of RC-PPARfl/fl mice by qualitative RT-PCR (Figure 2A
and online Figure S1B). Besides cortex, recombination in the
kidneys of RC-PPARfl/fl mice was also detected in inner
Figure 1. Effect of PPAR knockdown on mouse renin PPRE-
like driven transcription. Calu-6 cells were transfected with non-
targeting siRNA as control (siControl) or with PPAR sequence-
specific siRNA (siPPAR) and with the mPPREmPal3 construct.
A, Efficacy of the PPAR knockdown. Representative Western
blots of protein extracts probed with anti-PPAR or anti--actin
(used for loading control) antibodies. B, Effect of PPAR knock-
down on mPPREmPal3 activity. *P0.05 (n8 from 2 separate
experiments). RLA indicates relative luciferase activity.
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medulla where renin is known to be weakly expressed in
collecting ducts (Figure 2B).17 These data demonstrated that
recombination in kidney is not necessarily restricted to the JG
cells but may be present in other cell types where the
renin/cre allele is also active during development (eg, in
larger arteries) or in adults.17,18 Renin-expressing cells repre-
sent a very small fraction of total cells in the adult kidney.
Consistent with this, PPAR mRNA level decreased only
slightly in total kidney, cortex, or medulla of adult RC-
PPARfl/fl mice (online Figure S1C and S1D). This suggested
that cre-mediated recombination in cell types other than JG
would be minimal. We used single-cell RT-PCR to determine
whether PPAR is expressed by JG cells. By this method we
detected PPAR mRNA in single JG cells of wild-type mice,
whereas no signal was detected in the negative control
samples thus demonstrating the specificity of the signal
(Figure 2C). We also tested 5 different anti-PPAR antibod-
ies on histological kidney sections but could not reproducibly
detect any specific signal (data not shown). We next exam-
ined PPAR expression in primary cultures of native JG cells.
In these JG cell–enriched preparations, PPAR mRNA from
RC-PPARfl/fl was 30% of the level in RC-PPARwt/wt
mice (Figure 2D). These results were confirmed by single-
cell RT-PCR. In this study, only 30% of the JG cells (2 of 7
tested) isolated from RC-PPARfl/fl animals expressed
PPAR (Figure 2E), whereas all JG cells isolated from the
RC-PPARwt/wt mice were PPAR-positive (4 of 4 tested;
see online Figure S1E). The partial retention of PPAR
expression in JG cells of RC-PPARfl/fl mice may be attrib-
utable to single-allele excision that, however, could not be
discerned by the qualitative single cell RT-PCR. Based on
these assays, we concluded that PPAR expression is effi-
ciently knocked-out in the renin-producing JG cells of RC-
PPARfl/fl mice.
Increased Renin Production in
RC-PPARfl/fl Mice
After confirming the correct targeting of the PPAR knock-
out to the JG cells, we studied the renin production in
RC-PPARwt/wt and RC-PPARfl/fl mice. Immunohistochem-
ical staining of whole kidney slices revealed increased num-
ber of renin-positive glomeruli in RC-PPARfl/fl mice com-
pared with RC-PPARwt/wt mice (see online Figure S2A and
S2B). A few glomeruli (3 to 4, or 1% to 5% of total number
per slice) in RC-PPARfl/fl mice contained renin-producing
cells located not only in juxtaglomerular position but also
upstream in the afferent arteriolar wall (Figure 3A). This
arrangement of the renin-producing cells, known as recruit-
ment, is typically seen at chronic stimulation of renin expres-
sion in vivo. To confirm these semiquantitative findings we
measured renal renin mRNA levels and plasma renin concen-
tration (Figure 3B and 3C, respectively). Both methods
demonstrated unequivocally that there is a significant in-
crease of renin in RC-PPARfl/fl compared to RC-
PPARwt/wt mice. Allele-specific TaqMan assays revealed an
equivalent upregulation of Ren1 and Ren2 and confirmed an
increase in total renin mRNA (see online Figure S3).
Figure 2. Recombination of PPAR allele and PPAR expression in RC-PPARwt/wt and RC-PPARfl/fl mice. A, Qualitative PCR-based
screening for PPAR-recombined transcript in different organs of RC-PPARfl/fl mice. B, PPAR recombination in renal cortex and inner
medulla total RNA samples isolated from RC-PPARfl/fl mice. C, PPAR mRNA is expressed in native JG cells of wild-type mice. Lane
1, molecular weight marker; lanes 2 to 7, RT-PCR of serial dilutions of RNA isolated from single JG cells with PPAR-specific primers;
lane 8, “minus” RT (the sample was “reverse-transcribed” in the absence of transcriptase before amplification [negative control]); lane
9, water was reverse-transcribed and amplified (negative control). D, PPAR mRNA levels in primary cultures of native JG cells isolated
from RC-PPARwt/wt (n4) or RC-PPARfl/fl (n4) mice. PPAR and ribosomal L32 (internal control) mRNA levels were quantified by
real-time RT-PCR. *P0.05. E, Single-cell RT-PCR with renin-specific (top) or PPAR-specific (bottom) primers of total RNA extracted
from 7 different JG cells of RC-PPARfl/fl mice. The bands at the bottom of the gels represent primer dimers. St indicates length standard.
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Hematocrit Is Not Different Between
RC-PPARwt/wt and RC-PPARfl/fl Mice
Recombined PPAR transcript was detected in the inner
medulla of the kidney (Figure 2B) and could be explained by
the transcriptional activity of the renin gene observed in
medullary structures such as collecting ducts. Notably,
PPAR is also expressed in collecting duct principal
cells.19,20 PPAR has been reported to induce the expression
of ENaC subunit and presumably the salt/water reabsorption
in the terminal portion of the nephron.19,20 However, there
was no difference in the hematocrits in RC-PPARwt/wt and
RC-PPARfl/fl mice, thus excluding the possibility that the
recombination of PPAR in the medulla has resulted in
significant water deficit (Figure 4).
Arterial Blood Pressure and Pressure-Dependent
Control of Renal Blood Flow Are Not Different
Between RC-PPARwt/wt and RC-PPARfl/fl Mice
Although the finding that PPAR deletion in JG cells results
in increased renin expression in vivo is compatible with cell
culture data, it is still possible that systemic or local factors
are affected by the genetic manipulation and thus are respon-
sible for the altered renin production in RC-PPARfl/fl mice.
Arterial blood pressure plays a central role in the control of
renin synthesis and secretion.11 Interference with PPAR
function in the vasculature is accompanied by changes in
blood pressure.4–6,21 Therefore, we measured the blood pres-
sure in conscious mice. The average systolic blood pressure
(meanSD) was not significantly different between RC-
PPARwt/wt and RC-PPARfl/fl animals (120.76 versus
1177.6 mm Hg, P0.24; Figure 5A). These data are
representative for several measurements, with a total of
almost 20 animals per group performed either early in the
morning or in the afternoon (data not shown). Therefore, it is
unlikely that a minor decrease in blood pressure could have
stimulated renin production in RC-PPARfl/fl mice. In addi-
Figure 3. Renin expression in RC-PPARwt/wt and RC-PPARfl/fl mice. A, Costaining for renin (green) and vascular smooth muscle
-actin (red). Dashed circles show the position of glomeruli (G); arrows indicate renin immunoreactivity. B, Renal renin mRNA levels in
RC-PPARwt/wt (n6) and RC-PPARfl/fl (n8) mice. Renin and ribosomal L32 (internal control) mRNA levels were quantified by real-
time RT-PCR. *P0.05. C, Plasma renin concentration (PRC) in RC-PPARwt/wt (n8) and RC-PPARfl/fl (n8) mice. *P0.05.
Figure 4. Hematocrits in RC-PPARwt/wt and RC-PPARfl/fl
mice. Blood samples were obtained through mandibular bleed-
ing. The data are meansSD; n8 in each group.
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tion, in the isolated perfused kidney, we did not find any
significant discrepancy in the pressure-dependent control of
either renin release or renal vascular resistance between
RC-PPARwt/wt and RC-PPARfl/fl mice (Figure 5B and 5C,
respectively). Altogether, these results suggest that barore-
ceptor mechanisms are not responsible for the increased renin
observed in RC-PPARfl/fl mice.
Discussion
We have showed here that PPAR knockdown upregulates
the transcription of a luciferase reporter driven by the mouse
renin PPRE-like sequence. We found previously that RNA
interference–mediated knockdown of PPAR in the renin-
producing cell line Calu-6 upregulated the transcription of a
reporter gene driven by consensus PPRE.14 Thus, similarly to
PPAR agonists,13,14 the PPAR deficiency upregulates the
mouse renin PPRE-driven transcription. Although, at first
glance, these findings appear to be counter-intuitive, they are
in fact congruent to earlier data. Results from our group
demonstrated that the protein binding to PPRE increases in
response to PPAR deficiency.14 Because PPRE is generally
targeted by many nuclear receptors, we suggested that the
latter bind with higher affinity to PPRE at low cellular level
of PPAR, thus resulting in stronger trans-activation. In
agreement with this model knockdown of the PPAR inter-
action partner retinoid X receptor- also increased the bind-
ing to PPRE and upregulated the PPRE-driven transcrip-
tion.14 One more possible explanation is provided by studies
on dominant-negative PPAR mutants.22,23 In the absence of
ligand, PPAR is bound to PPRE complexed to corepressors
such as NCoR (nuclear corepressor) and SMRT (silencing
mediator of retinoid and thyroid receptors). These corepres-
sors are replaced by transcriptional coactivators (cAMP-
response element-binding protein-binding protein [CBP] and
steroid receptor coactivator-1 [SRC-1]) on binding of ago-
nists to PPAR. Dominant-negative PPAR mutants have
stronger affinity for corepressors which interfere with the
recruitment of coactivators in the presence of ligand.22,23 It is
therefore possible that the knockdown of PPAR diminishes
the amount of transcriptional corepressors bound to PPRE
and thus results in trans-activation. The potential relevance of
this mechanism, however, remains to be elucidated.
Based on these in vitro data and on our earlier findings
showing that PPAR targeted mouse renin promoter at a
PPRE-like motif in the distal enhancer,13 we predicted that
PPAR deficiency should increase the expression of the
mouse renin gene in vivo. To test this hypothesis, we crossed
two transgenic strains to obtain mice (RC-PPARfl/fl) with a
specific inactivation of PPAR in the renin-producing JG
cells by using the cre/lox recombination system. As expected,
PPAR mRNA was significantly diminished in primary
cultures of native JG cells isolated from JG-specific PPAR
knockout mice, and the majority of the JG cells in these
animals did not express PPAR. This finding provided
evidence for the correct targeting of recombination. As
predicted by the cell culture data, renin expression in kidneys
of RC-PPARfl/fl mice was increased compared to their
littermate controls. Consistently, plasma renin concentration
in RC-PPARfl/fl animals was also elevated. On the basis of
the cell-specific gene silencing observed, the increased renin
production in RC-PPARfl/fl mice could be primarily attrib-
uted to the deficiency of PPAR in their JG cells.
The recombination of the PPAR allele in medullary struc-
tures, such as the collecting duct, could possibly be responsible
for the increased renin production in RC-PPARfl/fl mice.
Several lines of evidence suggest, however, that this scenario
is quite unlikely. First, hematocrits were not different be-
tween RC-PPARwt/wt and RC-PPARfl/fl mice, thus arguing
against possible water deficit in the knockout animals. Sec-
ond, the baseline plasma and urine parameters of collecting
duct-specific PPAR-deficient mice were indistinguishable
from those of their inbred wild-type controls.20 Third, mice with
collecting duct-selective deletion of ENaC-isoform, which is
critical for the membrane translocation of the ENaC channel,
neither have impaired Na, K, or water balance nor were
protected against thiazolidinedione-induced water retention.24
We could not formally rule out that impaired tubular control of
renin production through the tubular macula densa mechanism is
causative for the increased renin in RC-PPARfl/fl mice. How-
ever, macula densa seems to be critical for the short-term, rather
than for the chronic regulation of renin synthesis.25
Recombination of PPAR allele was observed in aortas and
adrenals of RC-PPARfl/fl animals (see online Figure S1B). This
is in agreement with earlier data indicating that the renin
Figure 5. Arterial blood pressure and renal perfusion parameters of RC-PPARwt/wt and RC-PPARfl/fl mice. A, Systolic blood pressure
(SBP) measured by tail-cuff method. Each mark represents the value (average of 5 to 8 measurements) for a single animal (n10 for
each genotype). B and C, Pressure-dependent regulation of renin secretion rate (B) and renal vascular resistance (C) in isolated per-
fused kidneys of RC-PPARwt/wt and RC-PPARfl/fl mice (n3 and 4, respectively).
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promoter is active in these organs.17,26 Because recombinant
transcript was detected in some, but not all, RC-PPARfl/fl mice,
we suggested that this is most likely attributable to a
“dilution” of cre/renin-expressing cells in adulthood. The
same may be the case with other organs where the renin gene
is expressed, such as brain or testis, but where no PPAR
recombination was found.17 Consistent with this suggestion,
the robust expression of renin in the adrenal cortex during
fetal life occurs mostly in the large fetal zone, which
regresses after birth and is replaced by other cells presumably
originating from the outer cortex.27,28 In adult life, cells that
expressed renin (and therefore cre recombinase) persist in
some stripes along the adrenal cortex, with numerous adrenal
cells in between that never expressed renin and/or cre (spared
zones).17
We could not exclude that PPAR locus remained com-
pletely intact in the media cells of the afferent arteriole wall
upstream of the JG cells, because renin is produced in larger
arteries of the kidney during embryonic development and
early postnatal life.17,18 Moreover, PPAR is known to be
expressed, albeit weakly, in the vascular media layer, and the
specific inactivation of PPAR in smooth muscle cells has
been reported to result in impaired vascular reactivity.5,6,21
Changes in blood pressure induce reciprocal responses in
renin production in a way that increased blood pressure
inhibits, whereas lowered blood pressure stimulates renin
expression and release.11 Because renin, the limiting factor of
the renin–angiotensin system, is causally involved in the
regulation of blood pressure through the vasoconstrictor
angiotensin II, the blood pressure–dependent control of the
renin gene represents a feedback mechanism, which is deci-
sive for the overall cardiovascular homeostasis. We provided
three lines of evidence that, if present, the partial inactivation
of PPAR gene in renal and extrarenal vessels does not have
impact on the pressure control of renin in RC-PPARfl/fl
mice. First, the systemic blood pressure was not significantly
different between RC-PPARwt/wt and RC-PPARfl/fl ani-
mals. Second, the pressure-dependent control of renal blood
flow and consecutively renal vascular resistance were similar
in the two genotypes. Third, the pressure-regulated renin
release was also undistinguishable between RC-PPARwt/wt
and RC-PPARfl/fl mice, suggesting that there is no shift in
the pressure/flow rate sensitivity of the PPAR-deficient
afferent arterioles. In addition, the last two findings provided
indirect evidence against possible dysregulation of local
vasoactive mediator systems known to control renin produc-
tion, such as NO, prostanoids, adenosine, or endothelins in
RC-PPARfl/fl mice (see online Figure S4).
One could have expected that the hyperreninemia should
have increased the blood pressure in the JG-specific PPAR
knockout mice. However, transgenic mouse models demon-
strated that primary changes in renin/renin–angiotensin system
activity do not obligatory lead to blood pressure dysregulation,
basically because plasma renin–angiotensin system is only one
of the players in the complex regulation of circulation.29–31
Thus, the most plausible explanation for the increased
renin expression in RC-PPARfl/fl mice that we report here is
the deficiency of PPAR in the renin-producing cells. On the
basis of the compatible in vitro and in vivo data, we conclude
that the deficiency of PPAR in renin-producing cells in-
creases the expression of the mouse renin gene.
Perspectives
The results presented here provide evidence that PPAR is
relevant for the regulation of renin transcription in JG cells in
vivo. Our data demonstrated that RC-PPARfl/fl mice could
be used as a model for studying the PPAR in the regulation
of renin production in vivo and validated previous cell culture
findings.13,14 The in vitro results also predicted discrepant
modes of action of PPAR on mouse and human genes.14
Therefore, we are currently working on a transgenic model
that should reveal whether PPAR regulates the expression of
the renin gene in a species-specific manner.
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SUPPLEMENTAL METHODS 
The standard techniques used in our labs and applied in this study are described in details as 
follows: 
 
Isolation of single juxtaglomerular cells- Please see Supplemental References.
1,2
 In short, 
one male mouse (6-8 wk old) was killed
 
by cervical dislocation. The kidneys were extirpated, 
decapsulated,
 
and minced with a razor blade at 4°C. The minced tissue was incubated
 
under 
gentle stirring for 90 min at 37°C in 50 ml Buffer I [(in
 
mmol/L): 130 NaCl, 5 KCl, 2 CaCl2, 
10 glucose, 20 sucrose, and
 
10 Tris, pH 7.4] supplemented with 0.25% trypsin (Sigma) and 
0.05%
 
collagenase A (Boehringer). Next the tissue was sieved through
 
a 22.4-µm screen. The 
sieved cells were collected, washed, and
 
resuspended in 4 ml of Buffer I. The cell suspension 
was divided
 
into two tubes each containing 30 ml 30% isosmotic Percoll (Pharmacia)
 
in 
Buffer I and centrifuged at 25,000
 
g for 30 minutes  (4°C). Single large granular cells (JG 
cells) were transferred through modified patch pipettes
 
to 50 µL of guanidinium-thiocyanate 
solution. Ten micrograms
 
of yeast tRNA was added as a carrier, and total RNA was isolated 
followed by reverse transcription and PCR amplification for 60 cycles (for better 
visualisation, Figure 2C) or 40 cycles (for screening for renin or PPARγ expression, Figures 
2E and S1E). 
 
Isolation of native juxtaglomerular (JG) cell cultures- Please see Supplemental References.
2
 
Primary cultures from one RC-PPARγ
wt/wt
 and one RC-PPARγ
fl/fl
 mouse were prepared in 
parallel. In general, the protocol described above was used till centrifugation in Percoll/Buffer 
I. Four cellular layers with different specific renin activities
 
were obtained. The cellular layer 
(density = 1.07 g/mL) with the
 
highest specific renin activity was used for culture. Cells were 
incubated on 24-well plates for 1 day before subsequent RNA isolation. 
 
Immunohistochemistry- Please see Supplemental References.
3
 In short, kidneys from adult 
mice were fixed by perfusion with 4% paraformaldehyde and embedded in paraffin. 
Immunolabeling was performed on 5-µm sections incubated with chicken anti-renin IgG 
(diluted 1:200; Davids Biotechnologie GmbH, Regensburg, Germany) and mouse anti-αSMA 
IgG (diluted 1:100; Beckman Coulter-Immunotech, Krefeld, Germany). 
 
Protein extraction and Western blot- Please see Supplemental References.
2,4,5
 In short, 
samples were homogenized and lysed in protein lysis buffer (10 mmol/L TRIS, 1% SDS, 1% 
Nonidet P-40, 5 mmol/L Pefablock). Total cellular protein concentration was determined with 
Micro Protein Determination Kit (Sigma). Samples were boiled in Laemmli buffer for 5 
minutes and loaded on 10% SDS-polyacrylamide gels. After electrophoresis proteins were 
transferred to nitrocellulose membranes (BioRad) in transfer buffer (48 mmol/L TRIS,  39 
mmol/L glycine, 0.037% SDS, 20% methanol). The membranes were blocked, then incubated 
with 1:500-diluted rabbit polyclonal anti-PPARγ (Cell Signaling) or 1:1000-diluted mouse 
anti-β-actin  antibody. Bound antibody was detected with horseradish peroxidase-conjugated 
anti-rabbit IgG (DiaNova) followed by ECL detection (Santa Cruz) and exposure to Kodak 
Biomax MS film (Kodak). 
 
RNA interference, transient transfection and luciferase assay- Please see Supplemental 
References.
2,5
 In short, ready-to-use double-stranded siRNAs targeting human PPARγ was 
synthesized by Dharmacon (ON-TARGETplus siRNA SMARTpool L-003436-00). One 
hundred nanomol double-stranded non-targeting siControl siRNA (Dharmacon, used as 
control), or PPARγ-specific siRNA (siPPARγ) together with mPPREmPal3 firefly luciferase 
reporter vector (0.2 µg) and plasmid encoding
 
Renilla luciferase (pRL-0 vector, 0.01 µg; 
R2 
 
 3 
Promega) were transfected into Calu-6 cells using Dharmafect 2 transfection reagent 
(Dharmacon) according to the manufacturer’s protocol. Cells were harvested 72 hours after 
transfection. Relative luciferase activity (RLA) was calculated as firefly luciferase to renilla 
luciferase ratio. 
 
Isolated perfused kidney and plasma renin concentration (PRC)- Please see Supplemental 
References.
6,7
 In short, knockout mice and littermates (25-30 g body weight, males)  were 
used as kidney donors. The animals were anaesthetized with an intraperitoneal injection of 12 
mg/kg xylazine (RompunR, Bayer, Germany) and 80 mg/kg ketamine-HCl (Curamed, 
Germany), the abdominal aorta was cannulated, the right kidney was excised, placed in a 
thermostated moistening chamber and perfused at constant pressure (90 mmHg). Using an 
electronic feedback control, perfusion pressure was changed and held constant in a pressure 
range between 40 and 140 mmHg. Finally, the renal vein was cannulated and the venous 
effluent was collected for determination of renin activity and venous blood flow. 
The basic perfusion medium consisted of a modified Krebs-Henseleit solution supplemented 
with 6 g/100 mL bovine serum albumin and with freshly washed human red blood cells (10 % 
hematocrit). Renin activity in the venous effluent was determined by radioimmunoassay (Byk 
& DiaSorin Diagnostics, Germany). Renin secretion rates were calculated as the product of 
the renin activity and the venous flow rate [mL/min*g kidney weight]. Vascular resistance 
was calculated as pressure/flow ratio [mmHg*min*g kidney weight/mL]. For determination 
of PRC in vivo, blood samples were collected through mandibular bleeding. Plasma samples 
were then incubated for 1.5 hours at 37°C with plasma from bilaterally
 
nephrectomized male 
rats as renin substrate. The generated angiotensin
 
I [ng*mL
-1
*h
-1
] was determined by 
radioimmunoassay. 
 
RNA isolation, Reverse Transcription and Quantitative Light Cycler PCR- Please see 
Supplemental References.
2,5
 In short, total RNA was isolated using Qiagen RNeasy Spin 
Columns. Standard protocol for reverse transcription was used.  
Real time RT-PCR was performed with Light Cycler System (Roche, Mannheim, Germany). 
All PCR experiments were done using the Light Cycler-FastStart DNA Master SYBR Green I 
kit provided by Roche Molecular Biochemicals (Mannheim, Germany). Each reaction (20 µL) 
contained 2 µL cDNA, 3.0 mmol/L MgCl2, 1 pmol of each primer, and 2 µL of Fast Starter 
Mix (containing buffer, dNTPs, Sybr Green and Taq polymerase). The amplification program 
consisted of 1 cycle of 95° with 10-minute hold (”hot start”) followed by 40 cycles of 15 s 
95°C, 8 s 58°C, and 16 s 72°C. Amplification was followed by melting curve analysis 
(increasing the temperature of the reaction up to 95°C, by 0.1°C/s, starting at 50°C for 15s) to 
verify the correctness of the amplified product. The melting curves were converted to display 
the first negative derivative (-dF/dT) versus the temperature. This is an indication of the 
purity of the products, in which one melting point (Tm) is indicative for one product, while 
more melting points indicate the presence of more amplicons, e.g. by non-specific binding of 
one or both primers. To verify the accuracy of the amplification PCR products were further 
analyzed on ethidium bromide stained 2% agarose gel. The expression of renin, PPARγ, β1 
and β2 adrenoreceptors was quantified relative to ribosomal protein L32. For this purpose, a 
standard calibration curve was made. The Roche software uses the second derivative 
maximum method to calculate the fractional cycle numbers where the fluorescence rises 
above background. The crossing point  (Cp) is the point at which the rate of change of 
fluorescence is fastest. For the standard curve Cps are plotted versus log concentration for the 
standards. This standard curve is used to estimate the concentration of each sample.  
The efficiency of the PCR was calculated using the formula: Eff = 10
-1
/slope. 
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PCR-based detection of recombined PPARγ transcript was performed exactly as described by 
He et al.
8
 (please see Supplemental References) 
 
Renin allele-specific TaqMan assay 
Trizol (Invitrogen) and the Purelink
™
 RNA Mini Kit (Invitrogen) with on-column DNase 
treatment was used to extract kidney RNA.  For cDNA synthesis, 500 ng of total RNA was 
reverse transcribed using Superscript III (Invitrogen) in a total reaction volume of 20 µl. The 
cDNA was diluted 40X and 9 µl was used for quantitative real-time PCR.  Taqman
®
 assays 
were run using primer-probe sets and master mix from Applied Biosystems- Ren1 (Assay ID- 
Mm02342888_gH), Ren2 (Assay ID- Mm00651435_mH), and β-Actin (Part #- 4352933E). 
The specificity of Ren1 and Ren2 probes was tested using cloned cDNAs for each gene. 
 
 
Primers 
   forward    reverse 
renin   5’-atgaagggggtgtctgtggggtc-3’ 5’-atgtcggggagggtgggcacctg-3’ 
ribosomal 
protein L32  5’-ttaagcgaaactggcggaaac-3’  5’-ttgttgctcccataaccgatg-3’ 
PPARγ  5’-ccagctctacaacaggcc-3’  5’-gcttcaatcggatggttc-3’ 
β1 adrenoreceptor 5’-gctcaccaacctcttcatca-3’  5’-acagcacatctaccgaagtc-3’ 
β2 adrenoreceptor 5’-gagcgactacaaaccgtcac-3’  5’-tgggtggcacggtaccagtg-3’ 
 
The renin primers listed above amplify the product of both Ren1 and Ren2. 
 
 
 
SUPPLEMENTAL RESULTS 
Ren-cre and PPARγ-floxed mice were generated after recombination of the targeted loci in 
129 stem cells and were maintained in C57Bl/6 background. Strain 129 has two (Ren1d and 
Ren2), while strain C57Bl/6 has one (Ren1c) renin gene(s). Therefore the cre allele is 
accompanied by Ren2 gene (Figure S1A). Thus, mice heterozygous for the targeted renin 
locus which we used for the experiments (genotype RC) harbor one copy of each Ren1c and 
Ren2. This genetic background is the reason why we did not use genotype RR
fl/fl
 as littermate 
control - it has two copies of Ren1c and none of Ren2. 
The functional significance of the gene duplication of renin in mice is not well understood. In 
addition to the kidney, Ren2 is also strongly expressed in the submandibular gland. Ren1d and 
Ren1c are expressed predominantly in the kidney, thus corresponding to the general renin 
expression pattern observed in rats and humans. 
We obtained total 544 animals from breeding of Ren-cre with PPARγ-floxed mice. The nine 
possible genotypes were represented at Mendelian ratios as expected from the genotypes of 
the breeder pairs.  
There was no difference between kidney-to-body weight ratios (mean±SD) between littermate 
control (RC-PPARγ
wt/wt
) and JG-specific PPARγ knockout (RC-PPARγ
fl/fl
) mice (6.98±0.6 
versus 7.09±0.93 mg/g, n=5 in each group, p=0.44) indicating that renal growth was not 
affected in the knockout animals. 
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Figure S1 
A. Generation of double transgenic mice with targeted disruption of PPARγ allele in 
JG cells. Breeding scheme-  transgenic mice expressing cre recombinase from the 
endogenous renin locus were crossed with a second transgenic strain in which loxP 
sites flank exons 1 and 2 of the PPARγ gene. When recombination occurs the PPARγ 
gene is silenced. Crossing of double heterozygote parents produces nine possible 
genotypic variants in the progeny that are labeled according to the following scheme: 
R and C (for renin and cre respectively) refer to the alleles of the renin locus, while 
superscripted wt and fl (for wildtype and floxed respectively) refer to the alleles of the 
PPARγ locus. RC-PPARγ
wt/wt
 - littermate control, RC-PPARγ
fl/fl
 - juxtaglomerular 
(JG) specific PPARγ knockout; 
B. PPARγ recombination in aortas and adrenals of individual RC-PPARγ
fl/fl
 mice. 
Kidney cDNAs isolated from RC-PPARγ
wt/wt
 and RC-PPARγ
fl/fl
 mice were amplified 
as negative and positive controls respectively, St- length standard; 
C. PPARγ mRNA abundance in kidneys of RC-PPARγ
wt/wt
 (n=5) and RC-PPARγ
fl/fl
 
(n=6) mice. PPARγ and ribosomal L32 (internal control) mRNA levels were 
quantified by real-time RT-PCR; 
D. PPARγ mRNA abundance in renal cortex and inner medulla of RC-PPARγ
wt/wt
 
(n=4) and RC-PPARγ
fl/fl
 (n=6) mice. PPARγ and ribosomal L32 (internal control) 
mRNA levels were quantified by real-time RT-PCR. *P < 0.05. 
E. PPARγ mRNA is expressed in native JG cells of RC-PPARγ
wt/wt
 mice. Single-cell 
RT-PCR with renin (upper panel) or PPARγ (lower panel) specific primers of total 
RNA extracted from four different JG cells of RC-PPARγ
wt/wt
 mice. St- length 
standard. 
 
 
Recombination was detected in aortas and adrenals of individual knockout animals (five and 
two, respectively of ten RC-PPARγ
fl/fl
 mice tested) (Figure S1B) reflecting the developmental 
activity of renin promoter. PPARγ mRNA abundance tended to be lower in total kidney, 
cortex or medulla preparations of RC-PPARγ
fl/fl
 as compared to RC-PPARγ
wt/wt
 mice (Figure 
S1C,D). Our results confirmed previous studies which demonstrated that PPARγ is stronger 
expressed in medulla than in cortex (Figure S1D).
9,10
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Figure S2 
A. Immunohistochemical staining for renin of whole kidney cortical slices of RC-
PPARγ
wt/wt
 and RC-PPARγ
fl/fl
 mice; 
B. Number of renin-positive glomeruli in kidney slices of RC-PPARγ
wt/wt
 and RC-
PPARγ
fl/fl
 mice presented as percent of total glomeruli. 
 
 
We have used the number of renin-positive glomeruli as a rough estimate for renin 
expression. Previous 3D reconstruction studies of our group  have demonstrated that 
practically all glomeruli (> 95%) in the adult mouse kidney are renin-positive (K. Machura 
and A. Kurtz, personal communication).
3
 Therefore the number of renin-positive glomeruli 
per slide would statistically reflect the number of renin-expressing cells in the single afferent 
arteriole. 
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Figure S3 
Ren1 and Ren2 allele specific TaqMan assays (A. and B. respectively) in kidneys of 
RC-PPARγ
wt/wt
 (n=4) and RC-PPARγ
fl/fl
 (n=5) mice. 
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Figure S4 
Beta-adrenoreceptor (β1 and β2) mRNA abundance in kidney cortex of RC-
PPARγ
wt/wt
 (n=4) and RC-PPARγ
fl/fl
 (n=6) mice. β1, β2 and ribosomal L32 (internal 
control) mRNA levels were quantified by real-time RT-PCR. 
 
 
Renal sympathetic nerves and circulating catecholamines acting through beta-adrenoreceptors 
(β1 and possibly β2) located on the JG cell membrane are important for the regulation of 
renin expression in vivo.
11
 Moreover a very recent study demonstrated that PPARγ regulates 
the β2 adrenoreceptor expression in the vasculature.
12
 However, renal β1/β2 adrenoreceptor 
expression was not different between RC-PPARγ
wt/wt
 and RC-PPARγ
fl/fl
 mice implying that 
the adrenergic-dependent regulation of renin production is not affected by the local PPARγ 
deficit (Figure S4). 
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